Support sustained integration of HEOR and COA in early clinical development
Contribute to COA capability building and support the COA operating model to execute Lilly's overall COA strategy
Support development of disease-state and product-specific COA strategies with appropriate functional and cross-functional alignment
Execute COA strategies in partnership with functional and cross-functional teams to optimize impact
Contribute to collaboration models with cross-functional partners to measure patient voice of benefit-risk in drug development and regulatory decision making
Support early-phase HEOR strategy development in selected disease areas, such as neuroscience
Collaborate with HEOR colleagues to facilitate knowledge sharing across therapeutic areas, the HEOR Central team, and regional/affiliate teams
Execute work plans resulting in the development of relevant, reliable, and timely information for patients, regulators, clinicians, caregivers, and payers
Create scientific materials submitted to regulators, ensuring consistent quality
Publish research in peer-reviewed journals and present at scientific meetings
Support effective packaging of scientific materials for patients and caregivers for dissemination and disclosure
Develop effective working partnerships with project management teams to deliver planned work
Communicate project status regularly and transparently to function leaders
Contribute to the development and tracking of appropriate measures and metrics
Support COA capability building across business units and contribute to innovative COA solutions for early clinical development and integrated evidence generation
Collaborate with cross-functional teams to support early-phase HEOR strategy in selected neuroscience disease states
Develop effective collaborative working relationships with key cross-functional colleagues
Ensure compliance with appropriate internal and external standards and policies
Support HEOR therapeutic areas and regional teams in the development of COA strategies and capabilities
Support engagement with patient advocacy groups, regulators, external consortiums (e.g., Critical Path Institute Patient-Centered Evidence Consortium), disease-specific organizations, academic/government COA researchers, and other institutions
Partner with TA teams, GPS, regulatory, and other key cross-functional colleagues on external initiatives and environment-shaping activities
Monitor and understand the external environment and provide insights to inform future needs and priorities
Requirements
Doctorate (PhD, MD, or Pharm D) with 10 years, OR master's degree with 15+ years of experience in creating, executing, and delivering outcomes strategies/projects in a discipline relevant to Health Outcomes
Effective use of technical, leadership, and collaboration skills to be influential and respected across levels of the organization and cross-functionally
Relevant drug development and/or commercialization experience within the pharmaceutical industry with solid knowledge of patient, regulator, and payer requirements
Knowledge of the regulatory environment, including FDA Patient Focused Drug Development guidance, relevant guidances from other regulatory bodies, and evidentiary standards for Clinical Outcomes Assessment (e.g., PROs, ObsROs, ClinROs, PerfOs) label claims
Demonstrated subject matter expertise and scientific contributions in COA development and strategy
Demonstrated ability to contribute to and communicate scientific strategy to meet diverse, multi-stakeholder needs
Experience supporting the creation or expansion of organizational capabilities
Patient-focused qualitative and quantitative research experience across multiple therapeutic areas
Network of relevant external scientific and regulatory contacts desirable
Experience working with and through patient advocacy groups desirable
Domestic and international travel will be required.
Benefits
eligibility to participate in a company-sponsored 401(k)
pension
vacation benefits
eligibility for medical, dental, vision and prescription drug benefits
flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
life insurance and death benefits
certain time off and leave of absence benefits
well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)